Literature DB >> 20107166

The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model.

Jiazhu Fang1, Dan Fang, Phyllis B Silver, Feng Wen, Bing Li, Xiangrong Ren, Qing Lin, Rachel R Caspi, Shao Bo Su.   

Abstract

PURPOSE: Induction of tissue-specific experimental autoimmune diseases involves the use of complete Freund adjuvant containing Mycobacterium tuberculosis, whose recognition by the innate immune system depends on Toll-like receptors (TLRs) that signal through the adaptor molecule MyD88. The authors' previous study showed that MyD88(-/-) mice, but not TLR2(-/-), TLR4(-/-), or TLR9(-/-) mice, were resistant to experimental autoimmune uveitis (EAU).
METHODS: The EAU induction in mice deficient in TLR3 or mice double deficient in TLR2+4, TLR2+9, and TLR4+9 was examined and the role of the TLR agonists in the adjuvant effect involved in the induction of EAU was assessed.
RESULTS: TLR3-deficient and TLR2+4, TLR2+9, and TLR4+9 double-deficient mice were as susceptible to EAU as their control littermates. However, in mice immunized with a low-dose EAU regimen, TLR4 agonist lipopolysaccharide (LPS) enhanced EAU scores, delayed-type hypersensitivity responses, and antigen-specific T-cell proliferation. Antigen-specific IL-17 and IFN-gamma production by T lymphocytes was markedly increased in the LPS-treated group. The effects of LPS on EAU were abolished by treatment with an LPS deactivator polymyxin B. Inclusion of agonists for TLR2, TRL3, or TRL9 in immunization also enhanced EAU scores.
CONCLUSIONS: These results suggest that signaling of TLR2, TRL3, TRL4, and TRL9 is highly redundant in the adjuvant effect needed to induce EAU and that diverse microbial infections may contribute to the pathogenesis of diseases such as uveitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107166      PMCID: PMC2891468          DOI: 10.1167/iovs.09-4754

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  48 in total

1.  Array-based ELISAs for high-throughput analysis of human cytokines.

Authors:  M D Moody; S W Van Arsdell; K P Murphy; S F Orencole; C Burns
Journal:  Biotechniques       Date:  2001-07       Impact factor: 1.993

2.  Pertussis toxin alters the innate and the adaptive immune responses in a pertussis-dependent model of autoimmunity.

Authors:  Rajeev K Agarwal; Shu Hui Sun; Shao Bo Su; Chi-Chao Chan; Rachel R Caspi
Journal:  J Neuroimmunol       Date:  2002-08       Impact factor: 3.478

Review 3.  Genetic approaches to the study of Toll-like receptor function.

Authors:  Osamu Takeuchi; Shizuo Akira
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

4.  T cell mechanisms in experimental autoimmune uveoretinitis: susceptibility is a function of the cytokine response profile.

Authors:  R R Caspi; B Sun; R K Agarwal; P B Silver; L V Rizzo; C C Chan; B Wiggert; R L Wilder
Journal:  Eye (Lond)       Date:  1997       Impact factor: 3.775

5.  CpG oligonucleotides are potent adjuvants for the activation of autoreactive encephalitogenic T cells in vivo.

Authors:  B M Segal; J T Chang; E M Shevach
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

6.  MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways.

Authors:  R Medzhitov; P Preston-Hurlburt; E Kopp; A Stadlen; C Chen; S Ghosh; C A Janeway
Journal:  Mol Cell       Date:  1998-08       Impact factor: 17.970

7.  Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.

Authors:  O Takeuchi; K Hoshino; S Akira
Journal:  J Immunol       Date:  2000-11-15       Impact factor: 5.422

8.  Cutting edge: Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis.

Authors:  Norbert Reiling; Christoph Hölscher; Alexandra Fehrenbach; Svenja Kröger; Carsten J Kirschning; Sanna Goyert; Stefan Ehlers
Journal:  J Immunol       Date:  2002-10-01       Impact factor: 5.422

9.  Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells.

Authors:  Charles A Scanga; Julio Aliberti; Dragana Jankovic; Florence Tilloy; Soumaya Bennouna; Eric Y Denkers; Ruslan Medzhitov; Alan Sher
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

10.  Inhibition of experimental autoimmune myocarditis: peripheral deletion of TcR Vbeta 8.1, 8.2+ CD4+ T cells in TLR-4 deficient mice.

Authors:  Patricia A Gonnella; Hanspeter Waldner; Pedro J Del Nido; Francis X McGowan
Journal:  J Autoimmun       Date:  2008-08-19       Impact factor: 7.094

View more
  29 in total

1.  Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling.

Authors:  Cheng Luo; Xiangjun Yang; Angela D Kain; David W Powell; Markus H Kuehn; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-10       Impact factor: 4.799

2.  Investigation of the differential potentials of TLR agonists to elicit uveitis in mice.

Authors:  Jordan J Allensworth; Stephen R Planck; James T Rosenbaum; Holly L Rosenzweig
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

Review 3.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

4.  Characterization of microRNA expression profiling in peripheral blood lymphocytes in rats with experimental autoimmune uveitis.

Authors:  Dadong Guo; Jiao Li; Zhengfeng Liu; Kai Tang; Huixin Song; Hongsheng Bi
Journal:  Inflamm Res       Date:  2015-07-08       Impact factor: 4.575

5.  CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.

Authors:  Katherine J Wert; Alexander G Bassuk; Wen-Hsuan Wu; Lokesh Gakhar; Diana Coglan; MaryAnn Mahajan; Shu Wu; Jing Yang; Chyuan-Sheng Lin; Stephen H Tsang; Vinit B Mahajan
Journal:  Hum Mol Genet       Date:  2015-05-20       Impact factor: 6.150

6.  Mincle Activation and the Syk/Card9 Signaling Axis Are Central to the Development of Autoimmune Disease of the Eye.

Authors:  Ellen J Lee; Brieanna R Brown; Emily E Vance; Paige E Snow; Phyllis B Silver; David Heinrichs; Xin Lin; Yoichiro Iwakura; Christine A Wells; Rachel R Caspi; Holly L Rosenzweig
Journal:  J Immunol       Date:  2016-02-26       Impact factor: 5.422

Review 7.  DNA repair and systemic lupus erythematosus.

Authors:  Rithy Meas; Matthew J Burak; Joann B Sweasy
Journal:  DNA Repair (Amst)       Date:  2017-06-09

8.  CD14++CD16+ Monocytes Are Enriched by Glucocorticoid Treatment and Are Functionally Attenuated in Driving Effector T Cell Responses.

Authors:  Baoying Liu; Ashwin Dhanda; Sima Hirani; Emily L Williams; H Nida Sen; Fernando Martinez Estrada; Diamond Ling; Ian Thompson; Megan Casady; Zhiyu Li; Han Si; William Tucker; Lai Wei; Shayma Jawad; Amol Sura; Jennifer Dailey; Susan Hannes; Ping Chen; Jason L Chien; Siamon Gordon; Richard W J Lee; Robert B Nussenblatt
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

9.  Engagement of Toll-like receptor 2 enhances interleukin (IL)-17(+) autoreactive T cell responses via p38 mitogen-activated protein kinase signalling in dendritic cells.

Authors:  R Wei; L Dong; Q Xiao; D Sun; X Li; H Nian
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

Review 10.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.